Arianna Ardito

1.2k total citations
17 papers, 477 citations indexed

About

Arianna Ardito is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Arianna Ardito has authored 17 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 12 papers in Cancer Research and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Arianna Ardito's work include Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Hormonal Regulation and Hypertension (7 papers). Arianna Ardito is often cited by papers focused on Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Hormonal Regulation and Hypertension (7 papers). Arianna Ardito collaborates with scholars based in Italy, France and Germany. Arianna Ardito's co-authors include Massimo Terzolo, Fulvia Daffara, Barbara Zaggia, Silvia De Francia, Marco Volante, Alfredo Berruti, Paola Perotti, Sophie Leboulleux, Antonina Germano and Valentina Basile and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Endocrinology and European Journal of Surgical Oncology.

In The Last Decade

Arianna Ardito

16 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arianna Ardito Italy 12 402 325 238 141 33 17 477
Antonina Germano Italy 11 276 0.7× 265 0.8× 155 0.7× 120 0.9× 60 1.8× 14 362
Thomas Kerkhofs Netherlands 12 552 1.4× 406 1.2× 368 1.5× 160 1.1× 46 1.4× 20 637
Maria Candida Barisson Villares Fragoso Brazil 14 366 0.9× 200 0.6× 309 1.3× 82 0.6× 75 2.3× 48 500
Felix Megerle Germany 12 397 1.0× 290 0.9× 244 1.0× 129 0.9× 17 0.5× 17 446
H.R. Haak Netherlands 4 316 0.8× 219 0.7× 169 0.7× 99 0.7× 17 0.5× 8 346
G. Abiven France 3 557 1.4× 426 1.3× 358 1.5× 130 0.9× 28 0.8× 5 581
Alfredo Berruti Italy 9 647 1.6× 516 1.6× 395 1.7× 228 1.6× 36 1.1× 12 768
Olivia Barreau France 6 247 0.6× 295 0.9× 121 0.5× 81 0.6× 117 3.5× 6 363
Adam Andreasson Sweden 7 215 0.5× 218 0.7× 146 0.6× 36 0.3× 94 2.8× 9 339
Goslings Bm Netherlands 6 266 0.7× 173 0.5× 196 0.8× 80 0.6× 21 0.6× 11 324

Countries citing papers authored by Arianna Ardito

Since Specialization
Citations

This map shows the geographic impact of Arianna Ardito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arianna Ardito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arianna Ardito more than expected).

Fields of papers citing papers by Arianna Ardito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arianna Ardito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arianna Ardito. The network helps show where Arianna Ardito may publish in the future.

Co-authorship network of co-authors of Arianna Ardito

This figure shows the co-authorship network connecting the top 25 collaborators of Arianna Ardito. A scholar is included among the top collaborators of Arianna Ardito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arianna Ardito. Arianna Ardito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ardito, Arianna, Ettore Pelosi, Barbara Zaggia, et al.. (2015). 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. European Journal of Endocrinology. 173(6). 749–756. 11 indexed citations
2.
Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2015). Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?. Journal of Endocrinological Investigation. 39(4). 465–471. 11 indexed citations
3.
Ardito, Arianna, Barbara Zaggia, Vittoria Basile, et al.. (2015). Comparison between PET-CT and CT in the diagnosis of recurrence of adrenocortical carcinoma. Endocrine Abstracts.
4.
Cananzi, Ferdinando, Arianna Ardito, Luca Cozzaglio, et al.. (2014). Peritonectomy and hyperthermic intraperitoneal chemotherapy: Cost analysis and sustainability. European Journal of Surgical Oncology. 41(3). 386–391. 9 indexed citations
5.
Terzolo, Massimo, Silvia De Francia, Arianna Ardito, et al.. (2014). A current perspective on treatment of adrenocortical carcinoma. Expert Opinion on Orphan Drugs. 2(9). 911–921. 2 indexed citations
6.
Terzolo, Massimo, Barbara Allasino, A. Pia, et al.. (2014). Surgical remission of Cushing's syndrome reduces cardiovascular risk. European Journal of Endocrinology. 171(1). 127–136. 18 indexed citations
7.
Terzolo, Massimo, Fulvia Daffara, Arianna Ardito, et al.. (2014). Management of adrenal cancer: a 2013 update. Journal of Endocrinological Investigation. 37(3). 207–217. 72 indexed citations
8.
Libé, Rossella, Isabelle Borget, Cristina L. Ronchi, et al.. (2014). Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study.. Journal of Clinical Oncology. 32(15_suppl). 4106–4106. 1 indexed citations
9.
D’Avolio, Antonio, Silvia De Francia, Vittoria Basile, et al.. (2013). Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. Pharmacogenetics and Genomics. 23(6). 293–300. 35 indexed citations
10.
Terzolo, Massimo, Arianna Ardito, Matthias Kroiß, et al.. (2013). Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. European Journal of Endocrinology. 169(3). 263–270. 101 indexed citations
11.
Ferrero, Annamaria, Paola Sperone, Arianna Ardito, et al.. (2013). Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.. PubMed. 36(3). 148–52. 13 indexed citations
12.
Osella, G., M. Ventura, Arianna Ardito, et al.. (2012). Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. European Journal of Endocrinology. 166(5). 855–860. 23 indexed citations
13.
Terzolo, Massimo, Arianna Ardito, Barbara Zaggia, et al.. (2012). Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine. 42(3). 521–525. 29 indexed citations
14.
Ardito, Arianna, et al.. (2012). Mitotane treatment for adrenocortical carcinoma: an overview.. PubMed. 37(1). 9–23. 19 indexed citations
15.
Berruti, Alfredo, Paola Sperone, Annamaria Ferrero, et al.. (2011). Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. European Journal of Endocrinology. 166(3). 451–458. 104 indexed citations
16.
Reimondo, Giuseppe, Barbara Allasino, Silvia Bovio, et al.. (2011). Pros and cons of dexamethasone suppression test for screening of subclinical Cushing’s syndrome in patients with adrenal incidentalomas. Journal of Endocrinological Investigation. 34(1). e1–e5. 18 indexed citations
17.
Berruti, Alfredo, Paola Sperone, Elisa Bellini, et al.. (2011). Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma. Hormones and Cancer. 2(6). 378–384. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026